Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.14 USD | +1.04% | +2.47% | +14.53% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |